Chuck Royce

Royce & Associates

Chuck Royce is a prominent investor and the founder of Royce & Associates, known for its focus on small-cap investments. The firm employs a value-oriented investment approach, emphasizing thorough research and a long-term perspective. As of May 12, 2026, Royce & Associates has disclosed a total of 600 portfolio moves, with notable activity including position reductions, increases, and exits. The largest disclosed move involved trimming a position in Kyndryl Holdings, Inc. (KD) by approximately $45.2 million, reflecting the firm's dynamic trading strategy across various sectors, particularly in Industrials and Technology.

Latest Holdings

HoldingReported ValueWeightSharesLast PriceEst. ValueReturn
Telus Corporation Ordinary SharesTU · Q1 2026$210k0%16.3k$10.59$173k-17.6%
Qorvo, Inc. - Common StockQRVO · Q1 2026$205k0%2.7k$83.44$221k+7.8%
Scholastic CorporationSCHL · Q1 2026$205k0%5.2k$46.53$244k+19.1%
Helen of Troy LimitedHELE · Q1 2026$153k0%10.6k$28.67$305k+98.8%
Kohl's CorporationKSS · Q1 2026$141k0%10.9k$17.52$191k+35.8%
Oscar Health, Inc.OSCR · Q1 2026$115k0%10k$28.86$289k+151.6%
Bumble Inc.BMBL · Q1 2026$107k0%32.8k$3.03$99k-7.05%
Cricut, Inc.CRCT · Q1 2026$91k0%24.5k$4.63$113k+23.8%
05580M10805580M108 · Q1 2026$85k0%11.6k------
AMC Networks IncAMCX · Q1 2026$84k0%12.4k$10.90$136k+60.5%
European Wax Center, Inc.EWCZ · Q1 2026$81k0%14.1k$5.82$82k+0.69%
Taboola.com Ltd.TBLA · Q1 2026$76k0%24.6k$5.28$130k+70.3%
Angi Inc.ANGI · Q1 2026$76k0%11.1k$6.38$71k-6.86%
GoodRx Holdings, Inc.GDRX · Q1 2026$75k0%38.1k$3.02$115k+54.1%
Acacia Research CorporationACTG · Q1 2026$70k0%14.6k$4.60$67k-4.37%
ACCO Brands CorporationACCO · Q1 2026$65k0%21.5k$4.03$87k+34.3%
Repay Holdings CorpRPAY · Q1 2026$61k0%23.6k$4.06$96k+56.2%
Marqeta, Inc.MQ · Q1 2026$61k0%15k$17.89$269k+338.5%
Owens & Minor, Inc.OMI · Q1 2026$59k0%25.7k$2.68$69k+17.5%
MiMedx Group, Inc.MDXG · Q1 2026$58k0%14.7k$4.35$64k+10%
Udemy, Inc.UDMY · Q1 2026$56k0%12k$4.63$56k+0.22%
RESOURCES CONNECTION, INC.RGP · Q1 2026$54k0%14.6k$4.69$68k+25.7%
Akebia Therapeutics, Inc.AKBA · Q1 2026$39k0%28.4k$1.40$40k+0.72%
9.203E+1089.203E+108 · Q1 2026$36k0%16.8k------
Showing 751-774 of 774